FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1480344559> ?p ?o ?g. }

• W1480344559 endingPage "8" @default.
• W1480344559 startingPage "1121" @default.
• W1480344559 abstract "Head and neck squamous cell carcinomas (HNSCCs) are characterized by a marked propensity for local invasion and dissemination to cervical lymph nodes, with distant metastases developing in 30-40% of cases. Overexpression of the epidermal growth factor receptor (EGFR/c-erbB-1) and/or its ligands and high levels of certain matrix metalloproteinases (MMPs) have been associated with poor prognosis. The aim of this study was to examine the effects of EGFR ligands on gelatinase expression and invasion in HNSCC cell lines. We tested epidermal growth factor (EGF), transforming growth factor alpha, betacellulin, heparin-binding EGF, and amphiregulin and measured expression of gelatinases MMP-9 and MMP-2 in an established squamous carcinoma cell line (Detroit-562) and in two cell lines newly derived from patients with head and neck cancers (SIHN-005A and SIHN-006). Incubation of the cell lines with EGF-like ligands up-regulated MMP-9 (but not MMP-2) expression as measured by semiquantitative reverse transcription-PCR in a dose-dependent manner, with the effects being most marked in cells with high EGFR levels and undetectable in cells with low levels. Maximum stimulation was obtained in a concentration range of 10-100 nM. In addition, we confirmed by zymography that gelatinolytic activity consistent with MMP-9 (Mr 92,000) was up-regulated in parallel with increases in gene expression. Betacellulin (which binds both to EGFR and c-erbB-4 receptors) consistently increased MMP-9 expression and activation to a significantly greater degree than the other four ligands when tested at equimolar concentrations. In parallel with MMP-9 up-regulation, all EGF-like ligands increased tumor cell invasion through Matrigel in in vitro Transwell assays. These activities were independent of ligand effects on cell proliferation. Antagonist (ICR62) or agonist (ICR9) anti-EGFR monoclonal antibodies, respectively, inhibited or potentiated MMP-9 activity and tumor cell invasion induced by all ligands. Furthermore, a monoclonal antibody that neutralizes MMP-9 activity (Abl) also inhibited ligand-induced invasion of HNSCC. We confirmed that tumor cell lines used in these studies (and a larger series not reported here) generally expressed multiple c-erbB receptors and ligands. These results indicate that autocrine or paracrine signaling through EGFR potentiates the invasive potential of HNSCC via the selective up-regulation and activation of MMP-9. Furthermore, ligands such as betacellulin (which is commonly expressed in HNSCC), which can bind to and activate other c-erbB receptors, may be especially potent in this regard." @default.
• W1480344559 created "2016-06-24" @default.
• W1480344559 creator A5010891764 @default.
• W1480344559 creator A5011535887 @default.
• W1480344559 creator A5015731749 @default.
• W1480344559 creator A5025972115 @default.
• W1480344559 creator A5051107742 @default.
• W1480344559 creator A5086753354 @default.
• W1480344559 date "2000-02-15" @default.
• W1480344559 modified "2023-10-12" @default.
• W1480344559 title "Epidermal growth factor-like ligands differentially up-regulate matrix metalloproteinase 9 in head and neck squamous carcinoma cells." @default.
• W1480344559 cites W1501383613 @default.
• W1480344559 cites W1546229037 @default.
• W1480344559 cites W1585977131 @default.
• W1480344559 cites W1659037751 @default.
• W1480344559 cites W173973521 @default.
• W1480344559 cites W1838340609 @default.
• W1480344559 cites W1938617858 @default.
• W1480344559 cites W1965355187 @default.
• W1480344559 cites W1966408244 @default.
• W1480344559 cites W1966573085 @default.
• W1480344559 cites W1967726190 @default.
• W1480344559 cites W1983384550 @default.
• W1480344559 cites W1997399258 @default.
• W1480344559 cites W2005204942 @default.
• W1480344559 cites W2005707246 @default.
• W1480344559 cites W2016673597 @default.
• W1480344559 cites W2022916313 @default.
• W1480344559 cites W2029509704 @default.
• W1480344559 cites W2033584179 @default.
• W1480344559 cites W2034348985 @default.
• W1480344559 cites W2038086562 @default.
• W1480344559 cites W2039585676 @default.
• W1480344559 cites W2042502127 @default.
• W1480344559 cites W2045372146 @default.
• W1480344559 cites W2046197563 @default.
• W1480344559 cites W2046839159 @default.
• W1480344559 cites W2047694858 @default.
• W1480344559 cites W2050402158 @default.
• W1480344559 cites W2051982497 @default.
• W1480344559 cites W2053985126 @default.
• W1480344559 cites W2055149726 @default.
• W1480344559 cites W2074445842 @default.
• W1480344559 cites W2089356225 @default.
• W1480344559 cites W2100742787 @default.
• W1480344559 cites W2134570388 @default.
• W1480344559 cites W2145108148 @default.
• W1480344559 cites W2154523090 @default.
• W1480344559 cites W2154899220 @default.
• W1480344559 cites W2237146262 @default.
• W1480344559 cites W2238234884 @default.
• W1480344559 cites W2270009322 @default.
• W1480344559 cites W2406213538 @default.
• W1480344559 cites W2407795195 @default.
• W1480344559 cites W2419263944 @default.
• W1480344559 cites W2469736951 @default.
• W1480344559 cites W2135378702 @default.
• W1480344559 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10706134" @default.
• W1480344559 hasPublicationYear "2000" @default.
• W1480344559 type Work @default.
• W1480344559 sameAs 1480344559 @default.
• W1480344559 citedByCount "61" @default.
• W1480344559 countsByYear W14803445592012 @default.
• W1480344559 countsByYear W14803445592013 @default.
• W1480344559 countsByYear W14803445592014 @default.
• W1480344559 countsByYear W14803445592015 @default.
• W1480344559 countsByYear W14803445592016 @default.
• W1480344559 countsByYear W14803445592017 @default.
• W1480344559 countsByYear W14803445592018 @default.
• W1480344559 countsByYear W14803445592021 @default.
• W1480344559 crossrefType "journal-article" @default.
• W1480344559 hasAuthorship W1480344559A5010891764 @default.
• W1480344559 hasAuthorship W1480344559A5011535887 @default.
• W1480344559 hasAuthorship W1480344559A5015731749 @default.
• W1480344559 hasAuthorship W1480344559A5025972115 @default.
• W1480344559 hasAuthorship W1480344559A5051107742 @default.
• W1480344559 hasAuthorship W1480344559A5086753354 @default.
• W1480344559 hasConcept C109523444 @default.
• W1480344559 hasConcept C11957725 @default.
• W1480344559 hasConcept C121608353 @default.
• W1480344559 hasConcept C126322002 @default.
• W1480344559 hasConcept C142724271 @default.
• W1480344559 hasConcept C170493617 @default.
• W1480344559 hasConcept C2775960820 @default.
• W1480344559 hasConcept C2776232661 @default.
• W1480344559 hasConcept C2776362946 @default.
• W1480344559 hasConcept C2776530083 @default.
• W1480344559 hasConcept C2776833033 @default.
• W1480344559 hasConcept C2777546739 @default.
• W1480344559 hasConcept C2779013556 @default.
• W1480344559 hasConcept C2779438470 @default.
• W1480344559 hasConcept C2780806702 @default.
• W1480344559 hasConcept C2994460389 @default.
• W1480344559 hasConcept C502942594 @default.
• W1480344559 hasConcept C54355233 @default.
• W1480344559 hasConcept C71924100 @default.
• W1480344559 hasConcept C81885089 @default.
• W1480344559 hasConcept C86803240 @default.

• next